The Intracellular Proteome as a Source for Novel Targets in CAR-T and T-Cell Engagers-Based Immunotherapy
The impressive clinical success of cancer immunotherapy has motivated the continued search for new targets that may serve to guide potent effector functions in an attempt to efficiently kill malignant cells. The intracellular proteome is an interesting source for such new targets, such as neo-antige...
Main Authors: | Inbar Arman, Maya Haus-Cohen, Yoram Reiter |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/1/27 |
Similar Items
-
Harnessing antibody-mediated recognition of the intracellular proteome with T cell receptor-like specificity
by: Maya Haus-Cohen, et al.
Published: (2024-11-01) -
Current status and prospect of CAR-T cell immunotherapy for colorectal cancer
by: ZHANG Tianshuai, ZHOU Leqi, YU Guanyu, ZHANG Wei
Published: (2023-09-01) -
CAR-NK cells: A promising cellular immunotherapy for cancer
by: Guozhu Xie, et al.
Published: (2020-09-01) -
Ligand-based CAR-T cell: Different strategies to drive T cells in future new treatments
by: Alejandro Ramírez-Chacón, et al.
Published: (2022-09-01) -
Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments
by: Alejandro Ramírez-Chacón, et al.
Published: (2022-11-01)